CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF,
Frankfurt: 6PH) (“
CloudMD” or the
“
Company”), a healthcare technology and innovative
health services company transforming the delivery of care, is
pleased to announce that Mr. Gaston Tano has been appointed to its
Board of Directors, adding significant finance and audit depth.
Mr. Tano is a senior finance executive with over
30 years of diverse industry experience in multiple global public
companies. Since 2017, Mr. Tano has served as Senior Vice President
and CFO of Shawcor Ltd., a global material sciences company serving
the Infrastructure, Energy, and Transportation markets, which
generated over $1Bn in revenue in 2021. Previously, Mr. Tano held
the Senior VP and CFO position at Spin Master Ltd. (2011 to 2015)
and at CCL Industries Inc. (2008 to 2011). In addition, he held
several senior finance positions at Bacardi Ltd. (1995 to 2008).
Mr. Tano is a Canadian Chartered Professional Accountant (CPA, CA)
and a U.S. Certified Public Accountant (CPA, Illinois). He also
holds an Institute of Corporate Directors designation (ICD.D) from
Rotman School of Business, University of Toronto.
Karen Adams, Interim CEO of
CloudMD commented, “We are thrilled to add Gaston to our
Board of Directors as his finance expertise with globally
recognized companies will add significant value to our financial
and audit governance. Gaston brings over 30 years’ experience in
executive finance roles and we are grateful that he has decided to
join our board and support the Company through its growth.” She
continued, “CloudMD has positioned itself as an industry-leading
provider of comprehensive, employer healthcare and as we continue
to grow, corporate governance has become a strong priority for the
Company. We will continue to lean on our Board to adhere to
exceptional governance, accountability, and transparency in our
operations.”
“I am excited to join the Board of CloudMD and
support the Company as they continue to drive innovation and
disrupt the healthcare industry,” commented Gaston
Tano. “I believe my extensive senior financial expertise
will help guide the Company on their path back to profitable
financial sustainability and through its continued growth.”
As CloudMD continues to focus on growth and
sustainable profitability, it recognizes the importance for strong
leadership at both the management and Board levels. There have been
active discussions regarding the importance of the Company having
strong governance and financial acumen on the Board has been
emphasized. The appointment of Mr. Duncan Hannay to the Board in
2021 was one of the initial steps taken by the Company in executing
on such strategy and Mr. Tano’s appointment is the most recent. The
Board will continue to evolve and is expected to increase in size,
as well as the depth of its skills and strengths, as CloudMD
continues to grow. As a result, several potential Board members
have been identified, all of whom have skill sets that could
support the Company through its next phase of development. The
Company intends on adding an additional independent director in the
near term with additional depth to be added to the Board at the
Company’s next shareholder meeting.
About CloudMD Software &
Services
CloudMD is transforming the delivery of
healthcare using technology and by providing a patient-centric
approach, with an emphasis on continuity of care. By leveraging
healthcare technology, the Company is building one, connected
platform that addresses all points of a patient’s healthcare
journey and provides better access to care and improved outcomes.
Through CloudMD’s proprietary technology, the Company delivers
quality healthcare through a holistic offering including hybrid
primary care clinics, specialist care, telemedicine, mental health
support, healthcare navigation, educational resources, and
artificial intelligence (AI). CloudMD’s business is separated into
three main divisions: Clinics and Pharmacies, Digital Solution and
Enterprise Health Solutions, the Company’s fastest growing
division. CloudMD’s Enterprise Health Solutions Division has built
a leading employer healthcare solutions, including its
Comprehensive Integrated Health Services Platform, which offers one
comprehensive, digitally connected platform for educational
institutions, corporations, insurers, and advisors to better manage
the health and wellness of their students, employees, and
customers.
CloudMD currently services a direct ecosystem of
over 5,700 clinicians including, 1,800+ mental health
practitioners, 1,600+ allied health professionals, 1,400+ doctors
and nurses and covers 12 million individual lives across North
America. For more information
visit: https://investors.cloudmd.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
“Karen Adams”Interim Chief Executive Officer
FOR ADDITIONAL INFORMATION CONTACT:
Julia Becker VP, Investor
Relationsjulia@cloudmd.ca(604)785-0850
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
FORWARD-LOOKING STATEMENTS
This news release contains “forward-looking
statements” and “forward-looking information” within the meaning of
Canadian securities laws. Forward-looking statements in this news
release include, but are not limited to, statements regarding
changes to the Board, including increasing the number of directors.
These statements are based upon information currently available to
CloudMD’s management. All information that is not clearly
historical in nature may constitute forward‐looking statements. In
some cases, forward‐looking statements may be identified by the use
of terms such as “forecast”, “assumption” and other similar
expressions or future or conditional terms such as “anticipate”,
“believe”, “could”, “estimate”, “expect”, “intend”, “may”, “plan”,
“predict”, “project”, “will”, “would”, and “should”.
Forward-looking statements contained in this news release are based
on certain factors and assumptions made by management of CloudMD
based on their current expectations, estimates, projections,
assumptions and beliefs regarding their business and CloudMD does
not provide any assurance that actual results will meet
management’s expectations. While management considers these
assumptions to be reasonable based on information currently
available to them, they may prove to be incorrect. Such
forward‐looking statements are not guarantees of future events or
performance and by their nature involve known and unknown risks,
uncertainties and other factors, including those risks described in
the Company’s MD&A and most recent Annual Information Form
(which are filed under the Company’s issuer profile on SEDAR and
can be accessed at www.sedar.com), that may cause the actual
results, performance or achievements to be materially different
from any future results, performance or achievements expressed or
implied by such forward‐looking statements. Although CloudMD has
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward‐looking statements, other factors may cause
actions, events or results to be different than anticipated,
estimated or intended. There can be no assurance that such
statements will prove to be accurate as actual results and future
events could vary or differ materially from those anticipated in
such forward‐looking statements. Accordingly, readers should not
place undue reliance on forward‐looking information. CloudMD does
not undertake to update any forward-looking information, whether as
a result of new information or future events or otherwise, except
as may be required by applicable securities laws.
CloudMD Software & Servi... (TSXV:DOC)
Historical Stock Chart
From Mar 2024 to Apr 2024
CloudMD Software & Servi... (TSXV:DOC)
Historical Stock Chart
From Apr 2023 to Apr 2024